首页> 外文期刊>Urology >Localized amyloidosis of the urinary tract: case series of nine patients.
【24h】

Localized amyloidosis of the urinary tract: case series of nine patients.

机译:尿路局部淀粉样变性病:9例患者的病例系列。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To report 9 cases of primary localized amyloidosis of the urinary tract and correlate the pathologic findings with clinical and cystoscopic information. METHODS: Patients diagnosed with amyloidosis of the ureters, urinary bladder, or urethra from 1976 to 2003 were identified. Their medical records were reviewed, and histochemical and immunoperoxidase stains were performed on the tissue. RESULTS: Eight cases of amyloidosis of the urinary bladder and one of the renal pelvis/ureter were identified. None of our cases showed evidence of systemic amyloidosis. Of the 8 patients with amyloidosis of the urinary bladder, 5 presented with gross hematuria and 1 with irritative bladder symptoms and 2 had amyloidosis detected during cystoscopic follow-up for urothelial carcinoma. The patient with amyloidosis of the renal pelvis/ureter presented with flank pain and gross hematuria. The clinical impression was malignancy in 75% of the bladder cases. Most patients with bladder involvement were treated with localized bladder resection; however, 1 patient required total cystectomy for symptom control. Of 5 patients with follow-up information, 2 developed recurrence. The pathologic assessment diagnosed amyloid deposits consistent with primary or AL type amyloid in all cases. Immunoperoxidase stains revealed lymphoid cells in the vicinity of the amyloid deposits to be lambda-restricted in 78% of cases. CONCLUSIONS: Primary amyloidosis of the urinary tract is a rare condition that mimics malignancy in its clinical presentation and cystoscopic appearance and on diagnostic imaging. In our study, all cases of urinary amyloid deposits represented localized amyloidosis rather than manifestations of systemic amyloidosis. Monoclonal lymphoid populations evolving from chronic inflammation in the urinary tract may be the source of the amyloid AL proteins.
机译:目的:报告9例原发性尿路局部淀粉样变性病,并将病理结果与临床和膀胱镜检查信息相关联。方法:确定1976年至2003年诊断为输尿管,膀胱或尿道淀粉样变性的患者。审查了他们的病历,并对组织进行了组织化学和免疫过氧化物酶染色。结果:确定了8例膀胱淀粉样变性病和1例肾盂/输尿管。我们的病例均未显示系统性淀粉样变性病的证据。在8例膀胱淀粉样变性患者中,有5例表现为肉眼血尿,1例表现为膀胱刺激性症状,2例在膀胱镜随访中发现尿路上皮癌有淀粉样变性。患有肾盂/输尿管淀粉样变性的患者表现为胁腹疼痛和严重血尿。临床印象为75%的膀胱恶性肿瘤。大多数膀胱受累患者均接受了局部膀胱切除术治疗。但是,有1例患者需要进行全膀胱切除术以控制症状。 5例有随访信息的患者中,2例复发。在所有情况下,病理评估均诊断出与原发性或AL型淀粉样蛋白一致的淀粉样蛋白沉积物。免疫过氧化物酶染色显示,在78%的病例中,淀粉样沉积物附近的淋巴样细胞受到了λ限制。结论:尿路原发性淀粉样变性病是一种罕见的疾病,在其临床表现,膀胱镜外观以及诊断影像学上均能模拟恶性肿瘤。在我们的研究中,所有尿淀粉样沉积物病例均表现为局部淀粉样变性,而非全身性淀粉样变性的表现。由尿道中的慢性炎症演变而来的单克隆淋巴样群体可能是淀粉样蛋白AL蛋白的来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号